Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Berobenatide

A Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW)

Pfizer · Phase 3 · Recruiting · Enrollment 180

NCT07794761

ArmPopulationDoseWeeksEstimandWeight change
Treatment Arm 2Obesity or overweightn/rn/rn/rn/r
PlaceboObesity or overweightn/rn/rn/rn/r
Treatment Arm 3Obesity or overweightn/rn/rn/rn/r
Treatment Arm 1Obesity or overweightn/rn/rn/rn/r